Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Penumbra, Inc. Common Stock (NY:PEN)

279.40 -0.89 (-0.32%)
Streaming Delayed Price Updated: 9:39 AM EST, Nov 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Penumbra, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
3 Cash-Producing Stocks We Steer Clear Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
2 Healthcare Stocks to Keep an Eye On and 1 We Find Risky
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
News headline image
Here's How Much $1000 Invested In Penumbra 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Looking Into Penumbra Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
A Look Into Penumbra Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
A Look Into Penumbra Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Peering Into Penumbra Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? ↗
Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad double-digit jumps. 
Via Benzinga
News headline image
Datadog, Fastly, Planet Fitness, Air Products And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Penumbra (PEN) Q3 2025 Earnings Call Transcript ↗
Penumbra (PEN) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Why Penumbra (PEN) Stock Is Up Today
Shares of medical device company Penumbra (NYSE:PEN) jumped 17.2% in the morning session after it reported third-quarter 2025 financial results that surpassed Wall Street's expectations for both... 
Via StockStory
News headline image
Penumbra Shoots For A Breakout On 'Another Impressive Quarter' ↗
There are plenty of catalysts to like for the remainder or 2025 and into 2026, one analyst said. 
Via Investor's Business Daily
News headline image
Penumbra (NYSE:PEN) Delivers Strong Q3 Numbers, Stock Jumps 18.7%
Medical device company Penumbra (NYSE:PEN) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 17.8% year on year to $354.7 million. Its non-GAAP profit of $0.97 per... 
Via StockStory
News headline image
What To Expect From Penumbra’s (PEN) Q3 Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting results this Wednesday after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Penumbra (PEN) Shares Are Falling Today
Shares of medical device company Penumbra (NYSE:PEN) fell 5.5% in the afternoon session after the company announced results from its landmark STORM-PE randomized controlled trial. The study found that... 
Via StockStory
Topics Artificial Intelligence
News headline image
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing... 
Via Benzinga
Topics Economy
News headline image
Deep Dive Into Penumbra Stock: Analyst Perspectives (13 Ratings) ↗
 
Via Benzinga
News headline image
Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines? ↗
Penumbra pitted its device, Lightning Flash, with blood thinners vs. blood thinners, alone, in patients with pulmonary embolism. 
Via Investor's Business Daily
News headline image
Here's How Much You Would Have Made Owning Penumbra Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Penumbra (PEN) Stock Trades Up, Here Is Why
Shares of medical device company Penumbra (NYSE:PEN) jumped 3.2% in the morning session after Needham upgraded the stock to 'Buy' from 'Hold' and set a price target of $326. 
Via StockStory
Topics World Trade
News headline image
This Penumbra Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
9 Analysts Assess Penumbra: What You Need To Know ↗
 
Via Benzinga
News headline image
3 Low-Volatility Stocks We Approach with Caution
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Topics Economy
News headline image
$100 Invested In Penumbra 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Merit Medical Systems, ICU Medical, and Penumbra Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
News headline image
Here's How Much $100 Invested In Penumbra 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
1 High-Flying Stock to Own for Decades and 2 We Turn Down
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
Oscar Health, Penumbra, DexCom, Merit Medical Systems, and HCA Healthcare Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We’re Skeptical Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.